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In the 2000s, most of the female population of industrialised countries had access to mammography breast cancer screening, but with
variable modalities among the countries. We assessed the number of mammography units (MUs) in 31 European, North American
and Asian countries where significant mammography activity has existed for over 10 years, collecting data on the number of such
units and of radiologists by contacting institutions in each country likely to provide the relevant information. Around 2004, there were
32324MU in 31 countries, the number per million women ranging from less than 25 in Turkey, Denmark, the Netherlands, the
United Kingdom, Norway, Poland and Hungary to more than 80 in Cyprus, Italy, France, the United States and Austria. In a
multivariate analysis, the number of MUs was positively associated with the number of radiologists (P¼0.0081), the number of
women (P¼0.0023) and somewhat with the country surface area (P¼0.077). There is considerable variation in the density of MU
across countries and the number of MUs in service are often well above what would be necessary according to local screening
recommendations. High number of MUs in some countries may have undesirable consequences, such as unnecessarily high screening
frequency and decreased age at which screening is started.
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Biennial mammography screening is considered to reduce breast
cancer mortality by 25% in women aged 50–69 years (IARC, 2002).
In women aged 40–49 years, annual screening seems to reduce
breast cancer mortality by 15–17% (Moss et al, 2006). Since the
beginning of this millennium, most women living in industrialised
nations have had access to mammography screening. Therefore, for
instance, in 2005, X70% of women aged 50–69 years participated in
mammography screening in the Netherlands, France, Norway, the
United Kingdom and the United States (OECD, 2007). However,
there is considerable variation among countries (and sometimes
also between counties or provinces) in mammography screening,
including the age groups that are recommended for screening and
those for which it is reimbursed by health insurance, and in the
frequency of mammography (IARC, 2002; Lynge et al,2 0 0 3 ;S m i t h -
Bindman et al, 2003; Yankaskas et al, 2004; USPSTF, 2008).
Attendance can be by invitation from a screening programme, self-
reference, a doctor’s referral or through a combination of these
three. Variation in all these factors may influence the number of
mammography units (MUs) in countries. The objective of this study
was to estimate the number of MUs in European, North American
and Asian countries where significant mammography screening
activity has existed for over 10 years.
MATERIALS AND METHODS
For 34 countries, using address lists obtained from the Interna-
tional Agency for Research on Cancer (IARC) and through internet
searches, we gathered a list of potential sources of information. For
some countries, the data were readily available in published
reports or on websites; it was nonetheless verified through direct
contact with the sources. We wrote to all potential sources of
information we identified, asking for information on (i) the total
number of MUs (analogic and digital) and (ii) the total number of
radiologists, with numbers specialising in mammography.
The letter clearly stated that data sent to the IARC would be used
to make a comparison among countries. If a contact could not
provide relevant data, he or she was asked to provide us the details
of an appropriate institution or to forward our letter directly to
this institution.
We considered an MU to be any X-ray machine used for breast
examination, through either analogical or digital modalities. As the
same equipment could serve for both diagnosis and screening
purposes, we made no distinction between MU declared as serving
these purposes or reported as being part of a national screening
programme or a medical facility (e.g., hospital, breast clinic,
private radiology practice).
Between March and December 2006, we had contact with 229
potential sources of data, many of which forwarded our request to
more appropriate data source (details can be obtained from the
authors). We received data from 123 institutions or companies.
When we obtained data from several sources for one country, we
gave priority to radioprotection institutes, as registration of
X-ray-emitting devises is compulsory in all countries. Sometimes,
however, governmental radioprotection offices are established at a
sub-national rather than at a national level precluding the
identification of any single body having the relevant information
for the entire country. When radioprotection institutes did
not answer, or were not available at a national level, we turned
to alternative sources of information. When several sources
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yresponded, we used the one most likely to be aware of MU in the
country. Information from social security offices was usually not
considered, as for these institutions, a clinic or a radiological
facility is usually considered as a single ‘mammography centre’
although it may comprise more than one mammography unit.
When dissimilar data from at least two a priori reliable sources
were received for a country, we verified the information by
re-sending the letter to these sources and, when possible, to other
contacts. If for a country, no source of MU data was found, we used
data from the European Coordination Committee of the Radio-
logical and Electronical Industry (COCIR, 2003) or from the
Organisation for Economic Cooperation and Development (OECD,
2007). If the number of radiologists in a country could not be
obtained, we used data from the European Association of Radiology
(EAR, 2005). Data selected for each country are listed in Table 1.
As only five countries (Finland, Ireland, the Netherlands,
Sweden and the United Kingdom) provided separate counts of
MU used in national screening programmes and in other medical
Table 1 Sources of data on numbers of mammography (MM) units and radiologists
Information on:
Country Institute or company
a City
No. of
radiologists
No. of
MM units
Australia Australian Institute of Radiography Victoria X X
Austria Austrian Medical Chamber Vienna X
Austrian Research Centre Seiberdorf Seiberdorf X
Belgium Agence Fe ´de ´rale de Contro ˆle Nucle ´aire Bruxelles X
Royal Belgian Society of Radiology Bruxelles X
SPF Sante ´ Publique, Se ´curite ´ de la Chaı ˆne Alimentaire et Environnement Bruxelles X
Canada Mammography Accreditation Program MAP Que ´bec X X
The Royal College of Physicians and Surgeons of Canada Ottawa X
Cyprus Cyprus Medical Device Authority Pallouriotissa X
Czech Republic Charles University in Prague Prague X X
Denmark European Association of Radiology (EAR, 2005) X
Institute of Radiation Hygiene of Denmark
b Copenhagen X
Estonia No Information found
Finland Radiation and Nuclear Safety Authority Radiation Protection Helsinki X
France Agence Franc¸aise de Securite ´ Sanitaire des Produits de Sante ´ Paris X
Conseil National de l0Ordre des Me ´decins Paris X
Germany Coordination Committee of the Radiological and Electronical Industry (COCIR, 2003) X
The National Association of Statutory Health Insurance Physicians (KVB) Berlin X
Greece European Association of Radiology (EAR, 2005) X
Hellenic Ministry of Health
b Athens X
Hungary Health Physics Section (Roland Eo ¨tvo ¨s Phys Soc) of Hungary Budapest X
Hungarian National Institute for Hospital and Medical Engineering
b X
Hungarian Society of Radiologists Budapest X X
Iceland Iceland Cancer Registry and Iceland Cancer Society Reykjavik X X
Ireland Breast Check, The National Breast Cancer Screening Program Dublin X
European Association of Radiology (EAR, 2005) X
Radiological Protection Institute of Ireland Dublin X
Italy Societa ` Italiana di Radiologia Medica Milano X X
Japan Japan Radiological Society Tokyo X
Ministry of Health, Labour and Welfare X
South Korea Korean Association for Radiation Protection Seoul X X
Lithuania No information found
Luxembourg Ministe `re de la Sante ´ Luxembourg X X
Malta Malta Standards Authority Valletta X
New Zealand National Radiation Laboratory, a division of the Ministry of Health
b X
Norway European Association of Radiology (EAR, 2005) X
Norwegian Breast Cancer Screening Programme Oslo X
The Norwegien Radiation Protection Authority Oslo X
Poland Nofer Institute of Occupational Medicine Lodz X X
Radiation Protection Section Polish Society of Medical Physics Warsaw X
Portugal Ministry of Health Competent Authority
b X
Ordem dos Me ´dicos Lisbon X
Slovac Republic Soc of Nucl Med and Rad.Hygiene/Rad.Prot.Section Bratislava X X
Slovenia No information found
Spain Sociedad Espanola de Diagnostico por Imagen de la Mama Madrid X X
Sweden Swedish Medical Association Stockholm X
Swedish Radiation Protection Authority Stockholm X
Switzerland Office Fe ´de ´ral de la Sante ´ Publique Bern X X
The Netherlands Radiological Society of the Netherlands s-Hertogenbosch X X
Turkey Turkish Atomic Energy Commission adapted by Voyvoda et al (2007) X
United Kingdom NHS Cancer Screening Programmes Sheffield X X
USA Food and Drug Administration Rockville, MD X
Medical Marketing Service Inc Wood Dale, IL X
aThe complete list of institutions contacted in each country and the 122 institutions or companies that sent data can be obtained from the authors.
bData obtained from OECD
(2007).
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yfacilities, we did not use these in our analysis. Some countries gave
data on digital MU; given the rapid changes in digital mammo-
graphy equipment during the 2000s, it was considered premature
to provide these statistics.
We collected information of country breast screening practice
through literature search (e.g., Lynge et al, 2003; Yankaskas et al,
2004) and information gathered at the IARC. This information was
not requested to institutions contacted for the number of MUs, as
it was often known to be unavailable.
For each country, we computed the number of MUs divided by
the number of women in 2005. The population data source was the
Population Division of the Department of Economic and Social
Affairs of the United Nations (ESA, 2007). For defining the number
of MUs that would be necessary in a country, we took as a basis the
Netherlands and the United Kingdom, two countries with national
mammography screening programmes, where screening outside
the national programme is rare and where a participation of at
least 70% of the population was reached in 1995 in the United
Kingdom (women aged 50–64 years, triennial screening) (ACBCS,
2006) and in 1997 in the Netherlands (women aged 50–69 years,
biennial screening) (Otto et al, 2003). Computations in Table 2 are
based on data from the Netherlands because triennial screening
schedule exists only in the United Kingdom. We assumed three
sets of recommendations: (i) biennial screening of women 50–69
years old, (ii) annual screening for women aged 40–49 years and
of biennial screening at 50–69 years and (iii) annual screening at
40–69 years. The last scenario corresponds to recommendations
made in the United States by the American Medical Association,
the American College of Radiology and the American Cancer
Society (USPSTF, 2008). In the first, second and third scenarios,
about 20, 46 and 66MU per million women would be necessary,
respectively.
Using least square linear regression, we fitted a multivariate
model for the prediction of the number of MUs according the to
number of women of all ages, of radiologists and of country
surface. We fitted another model for European Union Member
States to examine the relationship between the number of MUs and
the percentage of women who had a mammography in the last 12
months. The latter data were taken from a survey done in the
European Union in 2006 that reported the percentages of women
50 years old and over who had a mammography examination in
the last 12 months, regardless of whether it was for screening or
for diagnostic purposes (Eurobarometer, 2007). The survey
distinguished between examination done after receiving an
invitation to attend the screening programme and that through
woman’s own initiative and that through a doctor’s initiative.
This study has been approved by the Institutional Review Board
of the IARC.
RESULTS
Of the 34 countries studied, we could not find data on the number
of MUs in three and on the number of radiologists in seven
countries. Data on the number of MUs were thus available for 31
countries, and data on the number of radiologist were available for
27 countries. Germany was the only country for which we could
not obtain data more recent than 2001.
Around 2004, there were 32324MU in 31 countries where
significant mammography screening was established. The number
of MUs per million women ranged from 13 in Turkey to 100 in
Austria (Table 3). There were less than 25MU per million women
in Turkey, Denmark, the Netherlands, the United Kingdom,
Norway, Poland and Hungary, whereas there were more than 80
in Cyprus, Italy, France, the United States and Austria. Sixteen
countries had more than 46MU per million women, and seven had
more than 66MU per million women.
Acquisition of digital mammography equipments was most
noticeable in Austria, Finland, France, Norway, Switzerland, Japan
and the United States, but data are not shown as the change from
analogical to digital mammography is now taking place rapidly in
a number of countries.
Eleven countries reported the number of radiologists specialised
in mammography examination (Table 3), ranging from 7% in South
Korea to 62% in Canada. In spite of the great variability in the
proportion of radiologists reported as being specialised in mammo-
graphy examination, a positive correlation existed between the
total number of radiologists and the number of radiologists specia-
lised in mammography examination (Pearson r coefficient¼0.80,
P¼0.0024). We then examined how female population size, the
number of radiologists and country surface influenced the number
of MUs by fitting a linear regression (Table 4). Both female
population size and the number of radiologists predicted the number
of MUs, whereas country surface was a less good predictor. More
complex models, including for instance variables related to age
groups being actually screened (when available) or population
density, were not better predictors of the number of MUs.
In Member States of the European Union, the number of MUs
was a good predictor of attendance to mammography screening
when attendance was due to self-reference or due to doctor’s
prescription, but not after invitation by a breast cancer screening
programme (Figure 1).
Table 2 Estimation of number of mammography (MM) units for annual screening of women 40–49 years old and biennial screening of women 50–69
years old, taking number of MM units in the Netherlands
Computation no. Parameter Computations Results
(1) Number of women of all ages in 2005 (million) 8.208
(2) Number of women 50–69 years old in 2005 (million) 1.881
(3) Number of women 40–49 years old in 2005 (million) 1.247
(4) Number of MM units, biennial screening of women 50–69* years old 162*
(5) Number of MM units, if annual screening of women 50–69 years old (4)*2 324
(6) Number of MM units per million women of all ages, biennial screening of women 50–69 years old (4)/(1) 20
(7) Number of MM units per million of women 50–69 years old, biennial screening (4)/(2) 86
(8) Number of MM units to install for annual screening of women 40–49 years old (3)*(7)*2 215
(9) Total number of MM units, annual screening of women 40–49 years old, and biennial screening of women
50–69 years old
(4)+(8) 377
(10) Total number of MM units, annual screening of women 40–69 years old (5)+(8) 539
(11) Number of MM units per million women of all ages, annual screening of women 40–49 years old, and
biennial screening of women 50–69 years old
(9)/(1) 46
(12) Number of MM units per million women of all ages, annual screening of women 40–69 years old (10)/(1) 66
*Number of MM units in the Netherlands in 2005.
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yDISCUSSION
This study shows the considerable variability in density of MU across
countries, and the number of MUs in service often exceeds what
would be necessary to fulfil local screening recommendations.
Country-specific volumes of breast cancer screening activities were
not examined because reliable quantitative data were not generally
available (Lynge et al, 2003; Yankaskas et al,2 0 0 4 ) .S i m i l a r l y ,a g ea t
screening and screening frequency could not be included in regres-
sion models. A strong discrepancy often exists between recommenda-
tions and actual practice. For instance, in France, biennial screening is
recommended for women aged 50–74 years, whereas as many as 60%
of French women aged 40–49 years reported at least one recent
screening (Spyckerelle et al, 2002). Furthermore, recommendations
may differ within the same country; according to health organisation
in the United States, seven bodies have issued different recommenda-
tions on age and frequency of screening (USPSTF, 2008).
The few data we had on the number of radiologists specialised in
mammography examinations suggested that the total radiologists
registered in a country could represent a reasonable approxima-
tion to those specialising in mammography. But the variability in
radiologists specialising between countries probably reflects
differences in what this entails. In some countries, geographical
distances may lead to installation of more MUs for easier access to
Table 3 Number of radiologists and of mammography units in 31 countries
a
Country
Number of women
of all ages in year
2005
b
Number of
radiologists
after 2002
Number of radiologists reported as
specialised in mammography
examination
Total number of
mammography
units
Mammography
units per million
women
Year of data for
mammography
units
Turkey 36314381 NA NA 493 14 2006
Denmark
c 2742913 1050 NA 54 20 2003
The
Netherlands
d
8208045 829 171 162 20 2005
e
United
Kingdom
d
30514714 2911 301 626 21 2005
Norway 2325518 430 NA 51 22 2006
Poland 19844491 2400 300 466 23 2005
e
Hungary 5289951 1200 180 127 24 2004
Czech
Republic
5244887 1293 NA 145 28 2003
Slovac
Repubic
2780891 530 118 80 29 2005
e
Ireland 2084588 180 NA 69 33 2005
Iceland 147000 26 NA 5 34 2007
Sweden 4554814 974 NA 174 38 2006
Canada 16274553 2039 1,259 656 40 2006
Luxembourg 235830 58 NA 10 42 2006
New
Zealand
2048740 268 NA 94 46 2004
Korea 23844230 2627 189 1136 48 2005
Japan 65506343 10556 1641 3,207 49 2005
e
Germany 42301156 6314 NA 2,163 51 2001
Spain 21915968 3895 371 1,140 52 2004
Belgium 5306707 1466 450 293 55 2006
Australia 10202449 1334 NA 645 63 2005
e
Malta 202454 NA NA 13 64 2006
Finland 2679104 NA NA 179 67 2006
Portugal 5422193 762 NA 366 68 2005
Greece 5625709 2500 NA 405 72 2005
Switzerland 3740073 654 NA 297 79 2005
Cyprus 428936 NA NA 36 84 2006
Italy 29898180 10000 1147 2560 86 2005
e
France 31032618 7392 NA 2700 87 2006
USA 151532730 24913 NA 13552 89 2006
Austria 4186019 950 150 420 100 2005
e
aMammography units include analogical and digital machines, being part or not being part of a national screening programme.
bFrom the Population Division of the Department of
Economic and Social Affairs of the United Nations.
cMammography screening programme organised in Copenhagen city and in two counties, covering 20% of Danish women
50–69 years of age (Jensen et al, 2004).
dCoverage of target population of 70% or more was achieved in 1995 in the United Kingdom (women 50–64 years old, triennial
screening) (ACBCS, 2006), in 1997 in the Netherlands (women 50–69 years old, biennial screening) (Otto et al, 2003) and in 2004 in Norway (women 50–69 years old,
biennial screening)(Vatten, 2007; Hofvind et al, 2007).
eYear of inventory not specified by data source and assumed as being data valid for 2005.
Table 4 Predictors of the number of mammography units in 27 countries, from a least square regression model
a including all variables in table
Variable Beta coefficient 95% confidence interval P-value
Number of radiologists 0.26 0.08; 0.45 0.0081
Total female population (in million) 0.35 0.04; 0.67 0.035
Country surface (in thousand square kilometer) 0.09  0.01; 0.18 0.077
Constant  447  713;  180 0.0029
aR
2 of model¼0.86.
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statistical association between country surface and the number of
MUs, once the number of radiologists and of women was taken
into account. However, similar densities observed in countries
much larger than the Netherlands, Norway and the United
Kingdom indicate that geographical factors cannot account for
all the difference in density of MU. Hence, all countries considered
together, both total female population and the number of
radiologists established in the country were the essential
determinants of the number of MUs, irrespective of country size.
Our data are more recent than the COCIR report (COCIR, 2003)
and cover more countries than the OECD reports (OECD, 2007).
Good agreement was found between our data and OECD data,
except that Spain, for which the OECD admitted that their data
could be underestimated (we received data from the Sociedad
Espanola de Diagnostico por Imagen de la Mama, see Table 1), and
for Korea, where the OECD got data from the Health Insurance
Review Agency, whereas our data came from the Korean
Association for Radiation Protection (Table 1), which was
probably more reliable than the former.
Examination of MU density in relation to the most recent
mortality data (He ´ry et al, 2008a,b) shows no evidence of a
correlation. In fact, until the late 1990s, breast cancer mortality
remained practically unchanged in some countries with a high MU
density (e.g., Belgium, France), whereas it decreased substantially
in several countries with a low density of MU (e.g., the United
Kingdom, the Netherlands).
Coverage of the female population at ages 50–69 years was not
achieved in Turkey and Denmark in 2003, though in Turkey, the
number of MU may have been underestimated (Voyvoda et al, 2007).
In Denmark, in 2003, mammography screening was offered to about
20% of women aged 50–69 years, and there was practically no
provision outside the national programme (Jensen et al, 2004).
A participation of the target population to the screening programme
of at least 70% was reached in 1995 in the United Kingdom (women
50–64 years old, triennial screening) (ACBCS, 2006), in 1997 in the
Netherlands (women 50–69 years old, biennial screening) (Otto et al,
2003), and in 2004 in Norway (women 50–69 years old, biennial
screening) (Hofvind et al, 2007; Vatten, 2007). The main differences
between these three countries and most other countries were the
higher screening frequencies and broader age groups to whom
screening was offered, by national programmes or by doctors.
Sixteen of the 31 countries included had more than 46MU per
million women and five have about twice this density. These data
suggest that in many countries the number of MUs is well above
what would be necessary according to local screening recommenda-
tions, and oversupply of MU may exist, peaking in France, Cyprus,
the United States, Austria and Italy. An oversupply of MU may
have undesirable consequences (Brown et al, 1990), which are
listed below. (i) Insufficient experience of radiologists in the inter-
pretation of mammograms for optimal sensitivity and specificity
(Smith-Bindman et al, 2005; The ´berge et al,2 0 0 5 ) .( i i )T h e
broadening of age ranges in which mammography is offered,
mainly women less than 40 years old. For instance, in Germany,
18% of first mammographies were in women below 30 years and
31% were in women aged 30–39 years (Klug et al, 2005). In United
States and in France, 47 and 45% respectively of first mammo-
graphies were in women below 40 years (Spyckerelle et al, 2002;
Colbert et al, 2004). (iii) An increasing frequency of mammography.
(iv) Increased costs of screening because of the necessity to amortise
and to pay the running costs of mammography centres.
The enforcement of the Mammography Quality Standard Act in
the United States in 1992 did not notably reduce the number of
MUs, but probably led to the creation of mammography facilities
that could better apply quality assurance requirements (Fischer
et al, 1998; Destouet et al, 2005).
The European Guidelines for Quality Assurance in Breast Cancer
Screening and Diagnosis exist since 1993 (Perry et al, 2006). There
are no data on the likely impact of these guidelines on the
installation of MU in European countries. An essential feature of
the European guidelines not present in the United States is the
recommendation to implement regular invitations to women for
mammography screening to maximise participation and regularity.
The positive correlation in Europe between the number of MUs per
million women and self-referred or prescribed participation in
mammography screening (and not after invitation) suggests that
globally speaking, screening attendance in the European Union is
not related to invitations by the programmes but rather to the
offering of mammography screening, which is itself tightly related to
the number of radiologists. In this respect, in high MU-density
countries, the introduction of an invitation-only programme could
not absorb and support the costs of the already functioning
mammography services. In such cases, such an introduction would
not, therefore, improve participation and reduce avoiding unneces-
sary screening, including outside the recommended age range.
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Figure 1 Relationship between the number of mammography units and
the percentage of women 50 years old and more in 21 countries of the
European Union reporting a mammography done in the last 12 months
related to (A) an invitation to attend mammography screening (Pearson’s
r coefficient¼0.06, P¼0.82); (B) own desire to have a mammography
screening or prescribed by a doctor (Pearson’s r coefficient¼0.58,
P¼0.0074). Data on mammography use from Eurobarometer (2007).
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